Corient Private Wealth
EQ icon

Corient Private Wealth’s Equillium EQ Stock Holding History

Corient Private Wealth’s Portfolio EQ Stock Details EQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,000
Closed -$8.23K – 2332
2024
Q4 		$8.23K Buy
+11,000
New +$9.1K ﹤0.01% 2319

Other funds holding EQ

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Corient Private Wealth's EQ Position: Q1 2025 in Review

Corient Private Wealth sold out of Equillium (EQ) in Q1 2025, closing a stake of 11,000 shares — an estimated $8.23K sold.

Corient Private Wealth first reported a position in EQ in Q4 2024 and held it in 1 quarter. The position peaked at $8.23K in Q4 2024. 24 funds tracked by Wall St. Rank hold EQ as of Q1 2025.

  • Corient Private Wealth reported no remaining Equillium position as of Q1 2025 after selling out during the quarter.
  • Corient Private Wealth sold 11,000 Equillium shares in Q1 2025, an estimated $8.23K.
  • Corient Private Wealth first reported a position in Equillium in Q4 2024 and held it in 1 quarter.
  • Corient Private Wealth's Equillium position peaked at $8.23K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held Equillium as of Q1 2025.

Based on Corient Private Wealth's 13F filing for Q1 2025, filed 14 May 2025.